CONMED Corporation

US$51.50As of Sun 8 Nov 2026, 12:00 UTC
NYSE:CNMDHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 3.52%
Div yield —
ROE 7.10%
Medical Devices
Beta (5Y) 0.90
PE TTM 21.39
TSR TTM 17.05%
Mkt cap US$1.535B
ROIC 5.35%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$50
(3.49%)
(97.26%)
Hold 3|9|2|3|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.78
0.77
0.78
0.81
9.30%
8.05%
5.16%
8.45%
Revenue$M
87.13
85.61
85.39
89.70
14.80%
10.14%
5.43%
5.33%
Peers (US$1.535B)
Cap (US$)
PE
1.567B
—
1.290B
—
1.519B
40.59x
Capital
TTM
5Y
10Y
Leveragex
1.026
0.131
0.136
EBIT/Intx
1.277
0.399
0.428
Own earn%
(99.60)
(12.10)
(23.31)
Sh yield%
49.04
20.78
22.62
Owners
Insiders/Inst%
11.79
71.93
Short interest%
4.81
SBC / revenue%
4.25
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
10–14
$1 testx
—
Incr. ROIC%
3